Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
Author(s) -
Stefanie Reis,
MariaInti Metzendorf,
Rebecca Kuehn,
Maria Popp,
Ildikó Gágyor,
Peter Kranke,
Patrick Meybohm,
Nicole Skoetz,
Stephanie Weibel
Publication year - 2022
Publication title -
cochrane library
Language(s) - English
Resource type - Journals
eISSN - 1465-184X
pISSN - 1464-780X
DOI - 10.1002/14651858.cd015395.pub2
Subject(s) - medicine , ritonavir , randomized controlled trial , medline , placebo , health care , covid-19 , scopus , intensive care medicine , alternative medicine , disease , family medicine , infectious disease (medical specialty) , human immunodeficiency virus (hiv) , viral load , pathology , antiretroviral therapy , political science , law , economics , economic growth
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom